Comparative evaluation of the quality of life of patients after mastectomy and non-flapped breast reconstructions for cancer
Purpose of the study: to compare the quality of life of patients who underwent mastectomy and non-flapped breast reconstructions for cancer. The study included 90 patients, diagnosed with breast cancer 0–IIA st. T 1–2 N 0 M 0 . The minimum age of the patients was 30 years old, the maximum was 65 years, the average age was (49.76 ± 8.54) years old. Patients were divided into three groups of 30 women depending on the type of surgical treatment of the tumor and breast reconstruction: 1st group – Madden surgery with a subsectoral expander installation and replacement with a silicone endoprosthesis, 2nd group – Madden surgery with prepectoral expander installation, staged lipofilling and replacement with silicone endoprosthesis, 3rd group – radical subcutaneous mastectomy with one-stage prepectoral breast reconstruction. The quality of life was assessed using a set of Breast-Q scales. The data obtained make it possible to draw conclusions about the effectiveness of subcutaneous mastectomy with one-stage prepectoral breast reconstruction according to the method proposed by the authors due to the tendency to a more intensive increase of the quality of life of patients at the stages of rehabilitation in such aspects as psychosocial, physical and sexual well-being.
Authors
- Samvel Vladimirovich Petrosyants (ORCID: https://orcid.org/0000-0003-0424-5286)
- Р. А. Пахомова (ORCID: https://orcid.org/0000-0002-3681-4685)
- D. N. Rovenskikh (ORCID: https://orcid.org/0000-0002-3672-1702)
- Dmitry Vladimirovich Ivanov (ORCID: https://orcid.org/0009-0002-9844-5210)
- A. N. Aydemirov
Institutions
- Novosibirsk State University (RU)
- Euromedic (PL)
- Stavropol State Medical University (RU)
Publication Details
- Journal
- Issues of Reconstructive and Plastic Surgery
- Published
- 2024-12-03
- DOI
- https://doi.org/10.52581/1814-1471/90/09
- Primary Topic
- Breast Implant and Reconstruction
- Type
- article
- Field-Weighted Citation Impact
- 0.00